W. Schubert et al., FLAVONOIDS IN GRAPEFRUIT JUICE INHIBIT THE IN-VITRO HEPATIC-METABOLISM OF 17-BETA-ESTRADIOL, European journal of drug metabolism and pharmacokinetics, 20(3), 1995, pp. 219-224
Naringenin, quercetin and kaempferol, which may be found in glycoside
form in natural compounds such as grapefruit, are potent inhibitors of
cytochrome P-450 metabolism. The influence of these flavonoids on the
metabolism of 17 beta-estradiol was investigated in a microsome prepa
ration from human liver. The flavonoids were added in concentrations o
f 10, 50, 100, 250 and 500 mu mol/l to the microsome preparation. The
metabolism of 17 beta-estradiol was concentration dependently inhibite
d by all the flavonoids tested. Addition of the flavonoids to the micr
osome preparation did not influence estrone formation, while a potent
inhibition of estriol formation was observed. At the highest concentra
tions tested of the respective flavonoid, there was approximately 75-8
5% inhibition of estriol formation. However, naringenin was a less pot
ent inhibitor of 17 beta-estradiol metabolism as compared to quercetin
and kaempferol. The most likely mechanism of action of the flavonoids
on 17 beta-estradiol metabolism is inhibition of the cytochrome P-450
IIIA4 enzyme, which catalyzes the reversible hydroxylation of 17 beta
-estradiol into estrone and further into estriol. These hydroxylation
processes represent the predominant steps of the hepatic metabolic con
version of endogenous as well as exogenous 17 beta-estradiol. This int
eraction would be expected to inhibit the first-pass metabolism of 17
beta-estradiol, and this has recently been demonstrated after oral adm
inistration of 17 beta-estradiol to women.